Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
about
Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Pharmacologically targeting th ...... gnaling and tumor progression.
@en
Pharmacologically targeting th ...... gnaling and tumor progression.
@nl
type
label
Pharmacologically targeting th ...... gnaling and tumor progression.
@en
Pharmacologically targeting th ...... gnaling and tumor progression.
@nl
prefLabel
Pharmacologically targeting th ...... gnaling and tumor progression.
@en
Pharmacologically targeting th ...... gnaling and tumor progression.
@nl
P2093
P2860
P356
P1476
Pharmacologically targeting th ...... gnaling and tumor progression.
@en
P2093
Houjian Cai
Iryna Lebedyeva
Junchen Liu
Omar Awad Alsaidan
Qianjin Li
Shaying Zhao
Sungjin Kim
Thomas Albers
P2860
P304
P356
10.1074/JBC.RA117.000940
P407
P577
2018-03-14T00:00:00Z